{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:33Z","timestamp":1740149853205,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12328-023-01866-y","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:01:40Z","timestamp":1696402900000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful prolonged treatment with sofosbuvir\/velpatasvir for a hepatitis C patient with decompensated cirrhosis and treatment failure after 12-week therapy"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7795-9463","authenticated-orcid":false,"given":"Hideyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-7983","authenticated-orcid":false,"given":"Ken","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2603-6000","authenticated-orcid":false,"given":"Jirou","family":"Takezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0402-1841","authenticated-orcid":false,"given":"Shoji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-4331","authenticated-orcid":false,"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-0964","authenticated-orcid":false,"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"1866_CR1","unstructured":"Japan Society of Hepatology guidelines for the management of hepatitis C virus infection. (ver 8.2). (in Japanese). https:\/\/www.jsh.or.jp\/lib\/files\/medical\/guidelines\/jsh_guidlines\/C_v8.2_20230316.pdf. Accessed 24 June 2023."},{"key":"1866_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","volume":"73","author":"JM Pawlotsky","year":"2020","unstructured":"Pawlotsky JM, Negro F, Aghemo A, et al. EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73:1170\u2013218.","journal-title":"J Hepatol"},{"key":"1866_CR3","unstructured":"HCV Guidance\u02d0 Recommendations for Testing, Managing, and Treating Hepatitis C. https:\/\/www.hcvguidelines.org. Accessed 24 June 2023."},{"key":"1866_CR4","unstructured":"Interview form of EPUCLUSA Combination Tablets, 5th edn. 2022; 76 (in Japanese). https:\/\/image.packageinsert.jp\/pdf.php?mode=1&yjcode=6250116F1025. Accessed 24 June 2023."},{"key":"1866_CR5","unstructured":"Interview form of EPUCLUSA Combination Tablets, 5th edn. 2022; 81 (in Japanese). https:\/\/image.packageinsert.jp\/pdf.php?mode=1&yjcode=6250116F1025. Accessed 24 June 2023."},{"key":"1866_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.241.45","volume":"241","author":"K Sato","year":"2017","unstructured":"Sato K, Hosonuma K, Yamazaki Y, et al. Combination therapy with ombitasvir\/paritaprevir\/ritonavir for dialysis patients infected with hepatitis C virus: a prospective multi-institutional study. Tohoku J Exp Med. 2017;241:45\u201353.","journal-title":"Tohoku J Exp Med"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00535-018-1503-x","volume":"54","author":"T Takehara","year":"2019","unstructured":"Takehara T, Sakamoto N, Nishiguchi S, et al. Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial. J Gastroenterol. 2019;54:87\u201395.","journal-title":"J Gastroenterol"},{"key":"1866_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12328-019-01029-y","volume":"12","author":"A Naganuma","year":"2019","unstructured":"Naganuma A, Sato K, Fukuchi T, et al. Successful prolonged treatment of glecaprevir\/pibrentasvir for chronic hepatitis C patient with treatment failure after 8-week therapy: a case report. Clin J Gastroenterol. 2019;12:592\u20137.","journal-title":"Clin J Gastroenterol"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/jpm12091517","volume":"12","author":"J An","year":"2022","unstructured":"An J, Park DA, Ko MJ, et al. Direct-acting antivirals for HCV treatment in decompensated liver cirrhosis patients: a systematic review and meta-analysis. J Pers Med. 2022;12:1517.","journal-title":"J Pers Med"},{"key":"1866_CR10","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","volume":"373","author":"MP Curry","year":"2015","unstructured":"Curry MP, O\u2019Leary JG, Bzowej N, et al. Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis. N Engl J Med. 2015;373:2618\u201328.","journal-title":"N Engl J Med"},{"key":"1866_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006128","volume":"96","author":"CY Chang","year":"2017","unstructured":"Chang CY, Nguyen P, Le A, et al. Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine (Baltimore). 2017;96:e6128.","journal-title":"Medicine (Baltimore)"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1002\/jmv.27157","volume":"93","author":"T Tada","year":"2021","unstructured":"Tada T, Kurosaki M, Nakamura S, et al. Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: a nationwide multicenter study by the Japanese Red Cross Liver Study Group. J Med Virol. 2021;93:6247\u201356.","journal-title":"J Med Virol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01866-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T16:12:52Z","timestamp":1706717572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01866-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient for being included in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}